Affiliation:
1. KK Women’s and Children’s Hospital, Singapore
2. National University Hospital, Singapore
3. Duke-NUS Medical School, Singapore
Abstract
ABSTRACT
Introduction: The use of drugs that modulate the immune system during paediatric severe sepsis and
septic shock may alter the course of disease and is poorly studied. This study aims to characterise these
children who received immunomodulators and describe their clinical outcomes.
Methods: This is a retrospective chart review of patients with severe sepsis and septic shock admitted into
the paediatric intensive care unit (PICU). Clinical, haematological and outcome characteristics of patients
with or without exposure to immune-modulating drugs were compared. Primary outcome was PICU
mortality; secondary outcomes were 28-day ventilator-free days (VFD) and intensive care unit-free days
(IFD). Univariate and multivariable analyses were performed for these outcomes.
Results: A total of 109 patients with paediatric severe sepsis or septic shock were identified. Of this
number, 47 (43.1%), 16 (14.7%) and 3 (2.8%) patients received systemic corticosteroids, intravenous
immunoglobulins and granulocyte colony stimulating factor, respectively. Patients who received
immune-modulating drugs were more likely to require invasive ventilation (38/54 [70.4%] versus 26/55
[47.3%], P=0.019) compared to those who did not. PICU mortality was indifferent between the 2 groups
(20/54 [37.0%] vs 11/55 [20.0%], P=0.058) even after accounting for chronic complex conditions and
admission organ dysfunction (PELOD score) (adjusted odds ratio 1.90, confidence interval [0.72–5.01],
P=0.193). However, VFD (19.5 [0–28] vs 25 [12–28] days, P=0.038) and IFD (15 [0–24] vs 22 [9–26]
days, P=0.024) were decreased in the immunomodulator group compared to the non-immunomodulator
group.
Conclusion: Immune-modulating drugs were frequently used in paediatric severe sepsis and septic
shock. Patients who received these drugs seemed to require more PICU support. Further studies are
required to examine this association thoroughly.
Keywords: Children, immunomodulatory drugs, infection, paediatric intensive care unit, sepsis
Publisher
Academy of Medicine, Singapore
Reference48 articles.
1. Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet 2020;395:200-11.
2. Tan B, Wong JJ, Sultana R, et al. Global Case-Fatality Rates in Pediatric Severe Sepsis and Septic Shock: A Systematic Review and Meta-analysis. JAMA Pediatr 2019;173:352-62.
3. Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, et al. The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir Med. 2018;6:223-30.
4. Wong JJ, Ho SX, Lee AOC, et al. Positive Fluid Balance is Associated with Poor Clinical Outcomes in Paediatric Severe Sepsis and Septic Shock. Ann Acad Med Singap 2019;48:290-7.
5. Esper AM, Moss M, Lewis CA, et al. The role of infection and comorbidity: Factors that influence disparities in sepsis. Crit Care Med 2006;34:2576-82.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献